Both in Pharmaceuticals
Niagen Bioscience vs Keros Therapeutics
Over the past year NAGE returned −65.2% and KROS returned −25.0%; their daily moves had a correlation of 0.25.
NAGE −65.2% KROS −25.0%Growth of $1, one year, split-adjusted
| Metric | NAGE | KROS |
|---|---|---|
| Price | $2.51 | $11.40 |
| Market cap | $198.6M | $226.0M |
| Today | +0.40% | +3.07% |
| 1 month | −17.4% | −0.7% |
| 6 months | −47.0% | +0.8% |
| Year to date | −60.5% | −44.0% |
| 1 year | −65.8% | −17.6% |
| Revenue growth (YoY) | −4.3% | −100.0% |
| Gross margin | 64.8% | — |
| Net margin | 3.2% | — |
| P/E (TTM) | 12.4× | — |
| Price / sales | 1.5× | 15.1× |
| Net cash | $66.7M | $257.6M |
| Dividend yield | — | — |
| Volatility (60d) | 48.0% | 46.4% |
| Short % of float | 7.5% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).